Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

Document and Entity Information - shares
3 Months Ended
Dec. 31, 2020
Feb. 10, 2021
Document and Entity Information    
Document Type 10-Q  
Document Period End Date Dec. 31, 2020  
Entity File Number 333-88480  
Entity Registrant Name NEUBASE THERAPEUTICS, INC.  
Entity Incorporation, State Code DE  
Title of 12(b) Security Common Stock, $0.0001 par value per share  
Trading Symbol NBSE  
Security Exchange Name NASDAQ  
Entity's Reporting Status Current Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   23,180,024
Entity Central Index Key 0001173281  
Current Fiscal Year End Date --09-30  
Document Fiscal Year Focus 2021  
Document Fiscal Period Focus Q1  
Amendment Flag false